Indole derivatives as serotonin reuptake inhibitors

Details for Australian Patent Application No. 2004249372 (hide)

Owner Merck Patent GmbH

Inventors Van Amsterdam, Christoph; Heinrich, Timo; Schiemann, Kai; Leibrock, Joachim; Bartoszyk, Gerd; Holzemann, Gunter; Bottcher, Henning; Seyfried, Christoph

Agent Davies Collison Cave

Pub. Number AU-B-2004249372

PCT Pub. Number WO2004/113326

Priority 103 26 939.8 16.06.03 DE

Filing date 24 May 2004

Wipo publication date 29 December 2004

Acceptance publication date 29 April 2010

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/113326 Priority application(s): WO2004/113326

29 April 2010 Application Accepted

  Published as AU-B-2004249372

26 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249389

2004249371-Indole derivative in the form of serotonin reabsorbing inhibitors